Report cover image

Global Long-acting Recombinant Human Erythropoietin Drugs Supply, Demand and Key Producers, 2023-2029

Publisher GlobalInfoResearch
Published Nov 08, 2023
Length 93 Pages
SKU # GFSH18297515

Description

Global Long-acting Recombinant Human Erythropoietin Drugs Supply, Demand and Key Producers, 2023-2029


The global Long-acting Recombinant Human Erythropoietin Drugs market size is expected to reach $ 1142.9 million by 2029, rising at a market growth of 4.0% CAGR during the forecast period (2023-2029).

Long-acting erythropoietin (EPO) drugs are a type of medication used to stimulate the production of red blood cells in the body. These drugs are primarily prescribed for individuals with certain medical conditions, such as anemia associated with chronic kidney disease or cancer treatment.

This report studies the global Long-acting Recombinant Human Erythropoietin Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Long-acting Recombinant Human Erythropoietin Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-acting Recombinant Human Erythropoietin Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Long-acting Recombinant Human Erythropoietin Drugs total production and demand, 2018-2029, (K Units)

Global Long-acting Recombinant Human Erythropoietin Drugs total production value, 2018-2029, (USD Million)

Global Long-acting Recombinant Human Erythropoietin Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Long-acting Recombinant Human Erythropoietin Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Long-acting Recombinant Human Erythropoietin Drugs domestic production, consumption, key domestic manufacturers and share

Global Long-acting Recombinant Human Erythropoietin Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Long-acting Recombinant Human Erythropoietin Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Long-acting Recombinant Human Erythropoietin Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Long-acting Recombinant Human Erythropoietin Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Johnson & Johnson and Kyowa Kirin, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-acting Recombinant Human Erythropoietin Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Long-acting Recombinant Human Erythropoietin Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Long-acting Recombinant Human Erythropoietin Drugs Market, Segmentation by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Global Long-acting Recombinant Human Erythropoietin Drugs Market, Segmentation by Application
Anemia
Kidney Disorders
Others

Companies Profiled:
Amgen
Johnson & Johnson
Kyowa Kirin

Key Questions Answered

1. How big is the global Long-acting Recombinant Human Erythropoietin Drugs market?

2. What is the demand of the global Long-acting Recombinant Human Erythropoietin Drugs market?

3. What is the year over year growth of the global Long-acting Recombinant Human Erythropoietin Drugs market?

4. What is the production and production value of the global Long-acting Recombinant Human Erythropoietin Drugs market?

5. Who are the key producers in the global Long-acting Recombinant Human Erythropoietin Drugs market?

Table of Contents

93 Pages
1 Supply Summary
2 Demand Summary
3 World Manufacturers Competitive Analysis
4 United States VS China VS Rest of the World
5 Market Analysis by Type
6 Market Analysis by Application
7 Company Profiles
8 Industry Chain Analysis
9 Research Findings and Conclusion
10 Appendix

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us